Accelerating the development of C-E Information: Does Phase IIIb represent an Opportunity

Marc L. Berger, MD, Executive Vice President & Senior Scientist, Life Sciences, OptumInsight, New York, NY, USA, ISPOR Washington DC, 2012.

View presentation.

You might also be interested in:

A Conversation with Scientist.com Founder and CEO Kevin Lustig 02/04/2021
ISPOR Offering Short Courses on Value Assessment Frameworks, HTA 06/19/2020
Minimizing Risk & Accelerating Timelines in Oncology Trials 11/18/2020
FDA Chief Vows to Permanently Adopt COVID-19 Measures to… 06/03/2020
Scientist.com to Acquire HealthEconomics.Com, the World’s… 12/15/2020
Designing Clinical Trials During COVID-19 ERA 02/11/2021
How COVID-19 is Impacting Outsourcing Engagements 04/15/2020